11-16 September 2011 The Unlimited World of Microbes

More documents

Recommendations

Info

34 Luncheon Seminar Thursday, 8 September Sponsored Session 13:00-14:00 Room A JSB Luncheon Seminar Sponsored by SHIONOGI & CO., LTD Convener: Yasuyoshi Ike URGENT NEED FOR PROMOTION OF RESEARCHES ON MOLECULAR MECHANISMS OF EMERGING MULTI- DRUG RESISTANCE Speaker: Yoshichika Arakawa Friday, 9 September 13:00-14:00 Room D JSB Luncheon Seminar Sponsored by Roche Diagnostics K.K. Convener: Shuolin Song METAGENOME, OUR SECOND GENOME Speaker: Shuolin Song 13:00-13:50 Room F MY5 Luncheon Seminar Respiratory Mycoses-Pulmonary Aspergillosis: Pathogenesis and Treatment Sponsored by Astellas Pharma Inc. Convener: Yoshihito Niki CHRONIC PULMONARY ASPERGILLOSIS ~NEW TREATMENT EVIDENCE AND EMERGENCE OF AZOLE-RESISTANT ASPERGILLUS FUMIGATUS IN JAPAN~ Speaker: Koichi Izumikawa PULMONARY ASPERGILLOSIS: PATHOGENESIS AND TREATMENT Speaker: David W Denning 13:00-14:00 Room H IFD1 Luncheon Seminar Antibiotic Resistant Organisms: Pediatrician's Perspective Convener: Kazunobu Ouchi Sponsored by Meiji Seika Pharma Co., Ltd. ANTIMICROBIAL RESISTANCE OF COMMUNITY ACQUIRED PATHOGENS IN PEDIATRIC FIELD Speaker: Satoshi Iwata Saturday, 10 September 11:00-12:00 Room H IFD4 Luncheon Seminar Antibiotic Choice in an Era of Multi-Resistance Convener: Koichi Izumikawa CHOOSING AN ANTIBIOTIC IN AN ERA OF MULTIRESISTANCE Speaker: David M Livermore Sponsored by SHIONOGI & CO., LTD.
Tuesday, 13 September XV International Congress of Virology 13:10-14:10 Room D+E JSV Luncheon Seminar Clinical impact of quadrivalent HPV vaccine on all HPV-associated diseases Sponsored by MSD K.K. Convener: Shoichi Onodera Speaker: Kei Kawana 13:10-14:10 Room C JSV Luncheon Seminar Antiviral resistance monitoring in human infl uenza in Japan, Myanmar and Lebanon Sponsored by DAIICHI SANKYO CO., LTD. Convener: Hiroshi Suzuki Speaker: Reiko Saito 13:10-14:10 Room F JSV Luncheon Seminar HPV genotyping by Pyrosequencing– Sentinel-base pyrosequencing and multiple sequencing primers method for genotyping of high-risk human papillomaviruses Sponsored by QIAGEN K.K. Convener: Stephane Perrey Speaker: Baback Gharizadeh Thursday, 15 September 13:10-14:10 Room D+E JSV Luncheon Seminar A new strategy for the treatment of respiratory virus infection - Possibilities of macrolides - Sponsored by Taisho Toyama Pharmaceutical Co., Ltd. Convener: Toshihiro Nukiwa Speakers: Mutsuo Yamaya Hiroshi Kido 13:10-14:10 Room C JSV Luncheon Seminar New mechanisms of vaccine adjuvant: innate immunity and beyond Sponsored by Takeda Pharmaceutical Co., Ltd. Convener: Yoshihiro Sakoda Speaker: Ken J Ishii 13:10-14:10 Room F JSV Luncheon Seminar Use of Pyrosequencing for Genotyping HCV and Identifying Mycobacteria species in a Diagnostic Laboratory Sponsored by QIAGEN K.K. Convener: Stephane Perrey Speaker: Jaber Aslanzadeh 35
Page 1: IUMS 2011 Sapporo FINAL PROGRAM XV
Page 4 and 5: Contents Greetings ................
Page 6 and 7: 4 [Sunday, 11 September] Sapporo Co
Page 8: 6 [Thursday, 15 September] Sapporo
Page 17 and 18: AV area located in the front of you
Page 19 and 20: Certifi cate of Attendance About th
Page 21 and 22: Offi cial Language The offi cial la
Page 24 and 25: 22 City of Sapporo About Sapporo We
Page 26 and 27: 24 Currency and Money Exchange Gene
Page 28 and 29: 26 Transportation Public Transporta
Page 30 and 31: 28 Program Committee Chair of Bacte
Page 32 and 33: 30 Kay Faaberg USA Ken Tyler USA Kl
Page 34 and 35: 32 National Scientifi c Committees
Page 38 and 39: 36 Evening Seminar Friday, 9 Septem
Page 40 and 41: 38 Previous IUMS Congresses Held tr
Page 43: Supported by Ajinomoto Co., Inc. Am
Page 46 and 47: 44 Opening Special Lecture Sunday,
Page 48 and 49: 46 Friday, 16 September 9:00-10:00
Page 50 and 51: 48 VI-SY2-4 A DNA REPAIR PROTEIN NB
Page 52 and 53: 50 VI-SY5-2 ELECTROPORATION OF LOW
Page 54 and 55: 52 VI-SY7-6 INFLUENZA POLYMERASE AC
Page 56 and 57: 54 VI-SY10-4 INDUCTION OF CASPASE A
Page 58 and 59: 56 VI-SY13-4 OPPOSITE EFFECT OF VAL
Page 60 and 61: 58 VI-SY16-3 ENZYME-LINKED IMMUNOSO
Page 62 and 63: 60 Tuesday, 13 September 11:25-12:5
Page 68 and 69: 66 Wednesday, 14 September 14:30-16
Page 70 and 71: 68 VI-SY30-2 E6 AND E7 VARIANTS OF
Page 72 and 73: 70 Wednesday, 14 September 16:30-18
Page 74 and 75: 72 Thursday, 15 September 11:25-12:
Page 76 and 77: 74 VI-SY37-2 ROLE OF MEMBRANES IN D
Page 78 and 79: 76 VI-SY39-6 STRUCTURE, ASSEMBLY AN
Page 80 and 81: 78 VI-SY42-6 LACK OF PRESENCE OF TH
Page 82 and 83: 80 Thursday, 15 September 14:30-16:
Page 84 and 85: 82 VI-SY48-4 BLOCKING OF FCR SUPPRE
Page 86 and 87:
84 VI-SY51-3 EFFICACY OF SINGLE EPI
Page 88 and 89:
86 VI-SY54-3 PERSISTENT EXPRESSION
Page 90 and 91:
88 Friday, 16 September 14:30-16:00
Page 92 and 93:
90 VI-SY60-3 VIROME IN BAT INTESTIN
Page 95 and 96:
Posters XV International Congress o
Page 97 and 98:
Poster 1 Discussion time: 10:15-11:
Page 99 and 100:
VI-PO2 Host Factors for Virus Repli
Page 101 and 102:
VI-PO2-24 CHROMATIN ENVIRONMENT-DEP
Page 103 and 104:
VI-PO1-15 EPITOPE MAPPING OF NEUTRA
Page 105 and 106:
VI-PO1-39 LIPIDOMICS ANALYSIS REVEA
Page 107 and 108:
VI-PO18-19 HEAT SHOCK PROTEIN 70 OV
Page 109 and 110:
VI-PO26-5 PLANT VIRUS CONTROL EMPLO
Page 111 and 112:
VI-PO8-4 ANTICANCER ACTIVITIES OF V
Page 113 and 114:
VI-PO27-7 HBV X PROTEIN OVERCOMES A
Page 115 and 116:
VI-PO21-23 CELLULAR MICRORNAS DIFFE
Page 117 and 118:
VI-PO13-23 ESTABLISHMENT OF A FELIN
Page 119 and 120:
VI-PO16-3 A SEROLOGICAL SURVEY OF R
Page 121 and 122:
VI-PO22-20 IDENTIFICATION OF COMMON
Page 123 and 124:
VI-PO7-12 THE AMINO ACID REQUIREMEN
Page 125 and 126:
VI-PO24-3 IDENTIFICATION OF COMPOUN
Page 127 and 128:
VI-PO24-27 NEWLY DEVELOPED A MULTIP
Page 129 and 130:
VI-PO32-8 SERO-PREVALENCE OF SWINE
Page 131 and 132:
VI-PO29-6 ADP-RIBOSYLATION FACTOR 1
Page 133 and 134:
VI-PO5-7 MASSIVELY PARALLEL SEQUENC
Page 135 and 136:
VI-PO5-30 MOLECULAR CHARACTERIZATIO
Page 137 and 138:
VI-PO5-51 COMPARISON OF REACTOGENIC
Page 139 and 140:
VI-PO43-2 BIOLOGICAL AND PHYSICAL P
Page 141 and 142:
VI-PO60 Virus Ecology and Tropical
Page 143 and 144:
VI-PO53-18 EMERGING HEMAGGLUTININ A
Page 145 and 146:
VI-PO52-12 EMERGENCE OF DENGUE IN K
Page 147 and 148:
VI-PO38-4 RT-MULTIPLEX PCR FOR DETE
Page 149 and 150:
VI-PO38-25 COMPARISON OF MICRO-FOCI
Page 151 and 152:
VI-PO35-11 CHARACTERIZATION OF A HI
Page 153 and 154:
VI-PO35-32 HIV-1 CDNA INTEGRATION A
Page 155 and 156:
VI-PO35-53 IN VITRO INHIBITORY ACTI
Page 157 and 158:
VI-PO51-6 HUMORAL IMMUNE RESPONSE T
Page 159 and 160:
VI-PO56-1 VI-PO56 Adenoviruses Thur
Page 161 and 162:
VI-PO47-4 EPIDEMIOLGY AND DISEASE A
Page 163 and 164:
VI-PO45-5 Withdrawn VI-PO45-6 CONST
Page 165 and 166:
VI-PO45-28 INFECTION OF MOUSE CELLS
Page 167 and 168:
VI-PO61-3 HIGH SUSCEPTIBILITY OF CU
Page 169 and 170:
VI-PO54-1 VI-PO54 Hepatitis C Thurs
Page 171 and 172:
VI-PO54-22 FREQUENCY OF HEPATITIS C
Page 173 and 174:
VI-PO55-6 IMMUNOPROTECTIVE EPITOPES
Page 176 and 177:
204 Outreach Program for Members of
Page 178:
FINAL PROGRAM XV International Cong
show all

11-16 September 2011 The Unlimited World of Microbes

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?